Kane Biotech Inc KNBIF

Primary Symbol: V.KNE

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc > Still cricket

<< Previous

Bullboard Posts

Next >>

Comment by francoisl13on Apr 04, 2024 9:35am

70 Views

Post# 35970061

RE:RE:RE:RE:RE:RE:RE:RE:RE:Still cricket

You beat me to the line:) We know that this STEM deal might be a game changer by allowing KNE to spend all resources on human health, I think that yesterday's volume was a sign that people are starting to accumulate shares and position themselves, I expect the volume to stay higher than usual until the news is released. Once released....well, will see then I guess.
P.S. I have to admit that I'm a little disappointed with them being late (again) and not communicating with the shareholders on this very important issue.
GLTA

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"